|Articles|December 16, 2013
- BioPharm International-12-16-2013
- Volume 2013 eBook
- Issue 1
Leveraging Development Strengths Drives Therapies to Market
Author(s)Cynthia A. Challener
NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Advertisement
Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
View other articles in the
Articles in this issue
almost 12 years ago
Creating Better Medicines through Better Conjugationalmost 12 years ago
Recovering Patent Life with Patent Term Extensionalmost 12 years ago
Strategic Outsourcing in Clinical Developmentalmost 12 years ago
Driving Innovation in Biopharmaceuticalsalmost 12 years ago
Crowdfunding Biopharmaceutical Innovationalmost 12 years ago
Restructuring for Biopharmaceutical SuccessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
2
AstraZeneca Next to Agree to MFN Deal: Report
3
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
4
Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part II. Biopharmaceutical Non-Sterile Equipment Cleaning
5
